Study reveals mechanism of lung-cancer drug resistance
Thursday, January 19, 2012 - 13:02
in Health & Medicine
New research published in Nature Medicine indicates that targeted drugs such as gefitinib might more effectively treat non-small cell lung cancer if they could be combined with agents that block certain microRNAs.